spacer
spacer

PDBsum entry 6h7m

Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Immune system PDB id
6h7m

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
107 a.a.
291 a.a.
120 a.a.
Ligands
2CV ×7
68H ×2
Metals
_NA ×2
Waters ×13
PDB id:
6h7m
Name: Immune system
Title: Activated turkey beta1 adrenoceptor with bound partial agonist salbutamol and nanobody nb6b9
Structure: Thioredoxin 1. Chain: e, f. Synonym: trx-1. Engineered: yes. Mutation: yes. Beta-1 adrenergic receptor. Chain: a, b. Synonym: beta-1 adrenoreceptor,beta-t. Engineered: yes.
Source: Escherichia coli (strain k12). Organism_taxid: 83333. Strain: k12. Gene: trxa, fipa, tsnc, b3781, jw5856. Expressed in: trichoplusia ni. Expression_system_taxid: 7111. Meleagris gallopavo. Wild turkey. Organism_taxid: 9103.
Resolution:
2.76Å     R-factor:   0.266     R-free:   0.285
Authors: T.Warne,P.C.Edwards,A.S.Dore,A.G.W.Leslie,C.G.Tate
Key ref: T.Warne et al. (2019). Molecular basis for high-affinity agonist binding in GPCRs. Science, 364, 775-778. PubMed id: 31072904 DOI: 10.1126/science.aau5595
Date:
31-Jul-18     Release date:   17-Oct-18    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P0AA25  (THIO_ECOLI) -  Thioredoxin 1 from Escherichia coli (strain K12)
Seq:
Struc:
109 a.a.
107 a.a.*
Protein chains
Pfam   ArchSchema ?
P07700  (ADRB1_MELGA) -  Beta-1 adrenergic receptor from Meleagris gallopavo
Seq:
Struc:
483 a.a.
291 a.a.*
Protein chains
No UniProt id for this chain
Struc: 120 a.a.
Key:    PfamA domain  Secondary structure
* PDB and UniProt seqs differ at 13 residue positions (black crosses)

 

 
DOI no: 10.1126/science.aau5595 Science 364:775-778 (2019)
PubMed id: 31072904  
 
 
Molecular basis for high-affinity agonist binding in GPCRs.
T.Warne, P.C.Edwards, A.S.Doré, A.G.W.Leslie, C.G.Tate.
 
  ABSTRACT  
 
G protein-coupled receptors (GPCRs) in the G protein-coupled active state have higher affinity for agonists as compared with when they are in the inactive state, but the molecular basis for this is unclear. We have determined four active-state structures of the β1-adrenoceptor (β1AR) bound to conformation-specific nanobodies in the presence of agonists of varying efficacy. Comparison with inactive-state structures of β1AR bound to the identical ligands showed a 24 to 42% reduction in the volume of the orthosteric binding site. Potential hydrogen bonds were also shorter, and there was up to a 30% increase in the number of atomic contacts between the receptor and ligand. This explains the increase in agonist affinity of GPCRs in the active state for a wide range of structurally distinct agonists.
 

 

spacer

spacer